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Ceramide is recognized as an intracellular lipid second
messenger, which induces various kinds of cell function
including apoptosis. To evaluate the competence of cera-
mide on the keratinocyte apoptosis, we examined effects
of a cell-permeable ceramide, N-acetylsphingosine (C2-
ceramide), on a human keratinocyte cell line, HaCaT.
C2-ceramide induced a distinct apoptosis in HaCaT cells
in a time-dependent manner, as inferred by morphologic
hallmarks of apoptosis such as bleb formation, cell body
shrinkage, nuclear chromatin condensation, and inter-
nucleosomal DNA fragmentation. In sharp contrast, an
inactive C2-ceramide, dihydroC2-ceramide, which lacks
the 4–5trans double bond, failed to induce the apoptosis.
The apoptotic HaCaT cells induced by C2-ceramide
showed a significant suppression of phospholipase D
(PLD) activity, regardless of the presence or absence
The human epidermis is a continuously renewing tissue,and its integrity is guaranteed by a regulated balance ofcell proliferation, cell differentiation, and cell death(Haake and Polakowska, 1993). Despite abundantinformation regarding proliferation and differentiation,
much less is known about apoptosis of epidermal keratinocytes.
Apoptosis is a programmed cell death characterized by morphologic
criteria that include chromatin condensation, DNA fragmentation, cell
shrinkage, and membrane blebbing (Vaux and Strasser, 1996; Hale et al,
1996). As a consequence of integrity of cellular membranes and
compartments, the surrounding cells are not affected and no inflamma-
tory reaction occurs as observed in necrotic cell death (Dvall and
Wyllie, 1986). Apoptotic cell death of keratinocytes, which shares
several structural and regulatory events with its death due to terminal
differentiation, is active in removing excessive and abnormal cell from
the epidermis (Fesus et al, 1991; Paus et al, 1993; Haake and Polakowska,
1993; Polakowska and Haake, 1994). Recent studies demonstrated that
UVB (Henseleit et al, 1996) and tumor necrosis factor-α in the presence
of the cycloheximide, induced apoptosis in the human keratinocyte
cell line, HaCaT cells (Reinartz et al, 1996).
The mechanisms underlying the apoptotic event, however, have not
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of guanosine 59-O-(3-thiotriphosphate) (GTPγS). This
indicates that C2-ceramide inhibits both GTPγS depend-
ent and GTPγS independent PLD. The membrane associ-
ated GTPγS dependent PLD activity was stimulated by
recombinant adenosine diphosphate-ribosylation factor.
The adenosine diphosphate-ribosylation factor depend-
ent and independent PLD activities were inhibited by
C2-ceramide in a concentration dependent manner, but
not by the inactive C2-ceramide. The concentration of
C2-ceramide to inhibit the membrane associated PLD
activity was comparable with that required for apoptosis
induction in HaCaT cells. It was thus suggested that
downregulation of PLD activity may be involved in the
mechanism underlying C2-ceramide induced ker-
atinocyte apoptosis. Key words: apoptosis/C2-ceramide/ker-
atinocytes HaCaT cell/ phospholipase D. J Invest Dermatol
110:376–382, 1998
yet been defined in this cell. Substantial evidence exists to support the
hypothesis that cytokines, such as tumor necrosis factor-α, interferon-
γ (Kim et al, 1991; Dressler et al, 1992), interleukin-1β (Ballou et al,
1992; Mathias et al, 1993), nerve growth factor (Dobrowsky et al,
1994), and Fas (Cifone et al, 1994), induce sphingomyelin hydrolysis
during the apoptotic process in several cell types. Recently, it has been
demonstrated that the conversion of sphingomyelin to ceramide via
sphingomyelinase would play a key role in apoptosis (Okazaki et al,
1989, 1990; Hannun, 1994). Indeed, both sphingomyelin and sphingo-
myelinase are reported to be present in the epidermis (Bowser and
Gray, 1978; Yardley and Summerly, 1981), and a role for sphingolipids
in senescence has been recently reported (Venable et al, 1994, 1995).
Ceramide is postulated to act as an inducer of apoptosis and exerts
typical morphologic changes in many types of cells (Hannun, 1996).
It should be noted that ceramides are the major component of the
extracellular lipids that comprise the epidermal permeability barrier
and their contents are increased during differentiation in keratinocytes
(Wertz and Downing, 1990). Cell-permeable ceramides are often used
for studying the mechanism of action of naturally occurring ceramides
in signal transduction. Actually, N-acetylsphingosine (C2-ceramide),
one of the most commonly employed analogs, induces apoptosis in
various cells, e.g., promyelocytic leukemia HL-60 cells (Okazaki et al,
1990) and primary cultured neurons (Brugg et al, 1996); however, in
keratinocytes, it has been reported that cell-permeable ceramides (C2-,
C6-, and C8-ceramide) induce cell differentiation (Wakita et al, 1994).
On the other hand, in addition to the multiple actions of ceramides
as a potent second messenger (Hannun, 1996), its inhibitory regulation
of phospholipase D (PLD) that hydrolyzes phosphatidylcholine (PC)
to produce phosphatidic acid and choline has recently been reported
(Gomez-Mun˜oz et al, 1994; Jones and Murray, 1995; Nakamura et al,
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1996; Venable et al, 1996). PLD is considered to play an important
role in cell growth and differentiation as reviewed by Exton (1994).
Recent studies have shown the existence of some isozymes of PLD
(1a, 1b, 2) by cDNA cloning from mammalian cells, and enzyme
properties of their overexpressed PLD isozymes were characterized
(Hammond et al, 1997; Colley et al, 1997; Kodaki and Yamashita,
1997). PLD1a and b have low basal activity and are activated by ADP-
ribosylation factor (ARF), Rho family GTP binding proteins, and
protein kinase C (PKC); however, the precise regulatory mechanisms
remain unknown. In some cases, agonist stimulated PLD activation is
associated with PI-PLC signaling that hydrolyzes phosphatidylinositol
4,5-bisphosphate, leading to diacylglycerol production followed by
PKC activation (Yeo et al, 1994). The other type, PLD2, has a very
high basal activity requiring phosphatidylinositol 4,5-bisphosphate and
is not responsive to small G proteins (ARF and Rho family) and PKC
(Colley et al, 1997). Despite a lot of information regarding the PLD
regulation, the functional roles of their isozymes remain to be defined.
Recently it was shown that PLD plays an important role in vesicular
trafficking (Exton, 1997). Although there is no direct evidence to
specify PLD isozymes involved in apoptosis, we have recently shown
that mRNA expression of three isozymes (rPLD1a, 1b, and c) changes
during C2-ceramide induced apoptosis of rat C6 glioma cells (Yoshimura
et al, 1997).
In this study, we have investigated the apoptotic effect of ceramide
on the human keratinocyte cell line, HaCaT cells, and then changes
in PLD activity during apoptosis.
MATERIALS AND METHODS
Cells culture The HaCaT cell line has been kindly supplied by Dr. T. Kuroki
(University of Tokyo, Tokyo, Japan) with permission from Dr. N.E. Fusenig
(German Cancer Research Center, Heidelberg, Germany) (1988). HaCaT cells
were grown in 100 mm cell culture dishes and maintained in Dulbecco’s
modified essential medium (Gibco-BRL, Grand Island, NY) supplemented
with 10% (vol/vol) fetal bovine serum (Irvine Scientific, Santa Ana, CA), 100
units penicillin per ml, and 100 mg streptomycin per ml in a humidified
atmosphere containing 5% CO2 at 37°C. Cells were passaged every 7 d at a
1:10 split. For apoptosis experiments, µ1 3 106 cells were grown in 100 mm
cell culture dishes for 48 h. The cells were washed twice with phosphate-
buffered saline and then cultured in Dulbecco’s modified essential medium
without fetal bovine serum. Various concentrations of C2-ceramide (Matreya,
Pleasant Gap, PA) were added to the culture medium without fetal bovine serum.
DNA fragmentation assay For DNA fragmentation assay, HaCaT cells
were centrifuged at 400 3 g for 10 min, washed twice in phosphate-buffered
saline, and resuspended in ice-cold lysis buffer containing 50 mM Tris-HCl
(pH 7.8), 10 mM ethylenediamine tetraacetic acid-Na, 0.5% (wt/vol) sodium-
N-lauroylsarcosinate (Wako, Osaka, Japan), and 1% Triton X-100. The lysates
were centrifuged at 20,000 3 g for 20 min and the resulting supernatants were
treated with proteinase K (0.1 mg per ml) (Boehringer, Mannheim, Germany)
and DNase-free RNase (10 µg per ml) (Boehringer) for 2 h at 37°C. Genomic
DNA was precipitated with ethanol and recovered by centrifugation at
20,000 3 g for 15 min. The resulting pellets were dissolved in Tris-ethylenedi-
amine tetraacetic acid buffer and electrophoresed on 2.0% agarose gel. The
DNA was stained with 0.01% (vol/vol) SYBRTM Green I solution (Wako) and
visualized under UV light and photographed (ATTO, Tokyo, Japan).
Measurement of DNA synthesis The assay of DNA synthesis was performed
according to the method described previously (Adachi et al, 1996). HaCaT cells
were plated in a concentration of 1 3 105 cells per well in 12 well tissue
culture clusters. After being grown to the subconfluent stage, serum was
removed and cells were further incubated for 24 h in the serum-free medium.
C2-ceramide (25 and 50 µM) was added to the medium and [3H]thymidine
(1.0 µCi per ml) (DuPont NEN, Boston, MA) was included for the last 6 h.
Total cells (touched and detached) were collected by centrifugation at 1800 3 g
for 10 min and washed three times with ice-cold phosphate-buffered saline.
The total cells were subjected to solubilization in 1 ml of 0.05% sodium dodecyl
sulfate solution containing 1 mM ethylenediamine tetraacetic acid and 100 µl
100% trichloroacetic acid. After being kept on ice for 10 min, the acidic
solution was filtrated with glass microfibre filter, GF/C (Whatman, Maidstone,
U.K.). The filter was washed three times with 1 ml of distillated water and
then with 1 ml of 95% ethanol. The radioactivity of the filter was determined
in Clear-sol I (Nacalai Tesque, Kyoto, Japan) in a liquid scintillation counter
(LS6500, Beckman, Fullerton, CA).
Assays for PLD activity HaCaT cells were washed twice in buffer A
[25 mM HEPES/NaOH buffer, pH 7.4, 100 mM KCl, 3 mM NaCl, 5 mM
MgCl2, 1 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-tetraacetic
acid, 5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 10 µg
leupeptin per ml] and resuspended in the same buffer. Cells were then disrupted
by nitrogen cavitation (600 psi at 4°C for 30 min). After unbroken cells were
removed by centrifugation at 900 3 g for 5 min, the resulting supernatant was
used as the cell lysate for experiments. The membranes were further separated
by centrifugation at 100,000 3 g for 60 min, washed once, and resuspended
in buffer A. For the cell-free PLD assay, cell lysates (5 µg) or membranes (1 µg
of protein) were premixed with 42 µM guanosine 59-O-(3-thiotriphosphate)
(GTPγS) (Boehringer) and 5.6 µM recombinant ARF1 (rARF1) at 4°C in a
volume of 120 µl of the solution of 20 mM HEPES/NaOH buffer, pH 7.4,
3 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-tetraacetic acid,
80 mM KCl, 2.5 mM MgCl2, 1 mM dithiothreitol, 1.2 mM CaCl2, and
400 mM NaCl. The substrate, composed of phosphatidylethanolamine (Sigma,
St. Louis, MO), phosphatidylinositol 4,5-bisphosphate (Sigma), PC (Sigma)
(16:1.4:1, molar ratio), and [choline-methyl-3H]dipalmitoylphosphatidylcholine
(60,000 dpm per assay), was prepared freshly by sonication in the form of
phospholipid vesicles (Brown et al, 1993). [3H]Dipalmitoylphosphatidylcholine
(50 Ci per mmol) was obtained from DuPont NEN. C2-ceramide dissolved in
chloroform:methanol (6:1, vol/vol) was evaporated under N2 gas and sonicated
in 20 mM HEPES/NaOH buffer, pH 7.4. The reactions were started by adding
the substrate to membranes or lysates and stopped with methanol/chloroform
(2:1, vol/vol) at indicated times, and lipids were extracted (Bligh and Dyer,
1959). Water-soluble products were separated and subjected to a column
chromatography with Dowex cation exchange resin (Cook and Wakelam,
1989). The resulting fractions were dissolved in scintillation cocktail (Clear-sol
I) and the radioactivity of [3H]choline was measured in a scintillation counter
(LS6500, Beckman).
Expression and purification of recombinant ARF Escherichia coli bearing
ARF1 plasmid was a generous gift from Dr. Joel Moss (National Institute of
Health, Bethesda, MD) and recombinant ARF1 was purified by column
chromatography (Hong et al, 1994).
RESULTS
Morphologic changes of HaCaT cells with C2-ceramide
treatment To examine whether ceramide induces apoptosis in
HaCaT cells, C2-ceramide, a short-chain cell-permeable analog, was
administered to HaCaT cells after incubation in a serum-free medium
for 12 h. When HaCaT cells incubated with 25 µM C2-ceramide for
different intervals were examined under the phase contrast microscope,
marked morphologic changes were seen to occur in a time dependent
manner (Fig 1). These included cell shrinkage, detachment from the
substratum, and blebbing of the cell membrane. HaCaT cells incubated
in the medium containing 10% serum were resistant to the same C2-
ceramide treatment. As shown in Fig 1(B–E), cells became round-up
3 h after the C2-ceramide treatment and the floating cells increased
time dependently. No significant morphologic changes were observed
in the control untreated cells cultured in the serum-free medium for
24 h (Fig 1A). C2-ceramide had marginal effect on the morphologic
changes at 10 µM, but at 50 µM for 9 h and at 100 µM for 3 h almost
all of the cells were detached within 9 h (data not shown).
It should be noted that an inactive C2-ceramide analog, dihydroC2-
ceramide (50 µM), which lacks the 4–5trans double bond in the
sphingosine chain, had no effect on the morphologic changes (Fig 1F).
Nuclear staining and DNA fragmentation in HaCaT cells treated
with C2-ceramide To examine whether the morphologic changes
induced by exogenous C2-ceramide were due to apoptosis, cells were
stained with Hoechst 33258. Nuclei of the control untreated HaCaT
cells were stained uniformly with this dye, indicating that the nuclei
were intact and the cells were viable (Fig 2A); however, treatment of
cells with C2-ceramide (25 µM) for 12 h resulted in nuclear fragmenta-
tion and condensation, which are characteristic of apoptosis (Fig 2B).
Further evidence indicating that C2-ceramide induced apoptosis in
HaCaT cells was provided by the characteristic pattern of intranucleo-
somal DNA fragmentation detected by agarose gel electrophoresis of
soluble cytoplasmic DNA (Fig 2C). On the other hand, no DNA
fragmentation occurred in cells treated with dihydroC2-ceramide
(25 µM) during 12 h incubation.
The extent of apoptosis induced by C2-ceramide was determined
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Figure 1. Temporal profiles of morphologic changes in HaCaT cells exposed to C2-ceramide. HaCaT cells were treated with 25 µM C2-ceramide
(B–E) and dihydroC2-ceramide (F) and were examined under the phase contrast microscope. A, untreated control; B, 3 h; C, 6 h; D, 9 h; E, 12 h; F, 12 h. Scale
bar, 20 µm.
quantitatively by staining the nuclear chromatin with Hoechst 33258.
As shown in Fig 3, C2-ceramide induced apoptosis in a concentration
dependent manner. Apoptotic cells were markedly increased over 9 h
incubation with 25 and 50 µM C2-ceramide, and µ40% of cells
displayed apoptotic morphologies at both concentrations after 12 h
treatment. These data clearly indicate that C2-ceramide induced
apoptosis in HaCaT cells. Because it has recently been reported that
the ability of ceramide to induce apoptosis is dependent on the cell
plating density in PC12 cells (Hartfield et al, 1997), HaCaT cells were
seeded at low density (1.7 3 10–5 cells per ml). Actually, the apoptotic
response to C2-ceramide was distinct at the low cell plating density,
but not at the high density.
Effect of C2-ceramide treatment on DNA synthesis in HaCaT
cells We examined the effects of C2-ceramide on the DNA synthesis
in HaCaT cells. As shown in Fig 4, [3H]thymidine incorporation into
control HaCaT cells showed a small gradual decrease. By contrast, the
addition of C2-ceramide (25 and 50 µM) caused a profound decrease
in the [3H]thymidine incorporation in a time dependent manner. The
C2-ceramide treatment abolished DNA synthesis at 25 µM by 12 h
incubation and at 50 µM by 9 h incubation. The temporal profile of
apoptosis as inferred by Hoechst 33258 staining was well correlated
with DNA synthesis inhibition.
Changes in PLD activity during C2-ceramide induced apoptosis
in HaCaT cells Recently, we have demonstrated that PLD activities
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Figure 2. Chromatin staining and DNA fragmentation in HaCaT cells
treated with C2-ceramide. HaCaT cells were incubated in the absence (A)
and presence (B) of 25 µM C2-ceramide for 12 h. Nuclei were stained
with Hoechst 33258 as described in Material and Methods, and fluorescence
photographs were taken under a fluorescent microscope; scale bar, 10 µm. The
photographs are representatives from at least three different cultures. (C)
Genomic DNA was extracted from various cells as described in Materials and
Methods. Intranucleosomal DNA fragmentation was visualized by staining with
SYBRTM Green I after agarose gel electrophoresis. Lane a, untreated control
cells; lane b, C2-ceramide treated cells; lane c, dihydroC2-ceramide treated cells;
lane m, ladder marker 123 bp.
Figure 3. Time dependent apoptosis by C2-ceramide in HaCaT cells.
HaCaT cells were treated without 25 µM (s), with 25 µM (d), or with
50 µM (j) C2-ceramide for the indicated times. Levels of apoptosis were
quantitatively determined by counting the typical apoptotic Hoechst 33258
stained cells as shown in Fig 2(B). Results are represented as mean 6 SD from
at least three separate experiments.
Figure 4. Effect of ceramide on DNA synthesis in HaCaT cells. HaCaT
cells were incubated in the absence of 25 µM (u), in the presence of 25 µM
(j), or in the presence of 50 µM (u) C2-ceramide for the indicated times and
[3H]thymidine was present for the last 6 h of the incubation. All the cells
(touched and detached) were collected and the number of cells were counted.
The [3H]thymidine incorporation was measured as described in Materials and
Methods. Results are expressed as [3H]thymidine incorporated per 1 3 104 cells
and are represented as the means 6 SD from three experiments performed
in duplicate.
were changed during C2-ceramide induced apoptosis in C6 glial cells
(Yoshimura et al, 1997). In this study, PLD activity was examined
using [3H]PC substrate during the apoptotic process caused by C2-
ceramide in a cell-free system of HaCaT cells. It is known that there
are two types of PLD, GTPγS independent and GTPγS dependent
(Exton, 1997). When assayed in the control HaCaT cell lysate, the
[3H]choline releases were increased either in the absence (Fig 5A) or
in the presence (Fig 5B) of GTPγS in a similar time dependent manner,
indicating the presence of both GTPγS-independent and GTPγS-
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Figure 5. Time-dependent PLD activities in control and C2-ceramide
induced apoptotic HaCaT cell lysates. HaCaT cells were treated without
(s) or with (d) 25 µM C2-ceramide for 12 h and subjected to nitrogen
cavitation for preparation of cell lysates. The PLD activities were determined
using the cell lysates in the absence (A) or presence (B) of 40 µM GTPγS by
measuring released [3H]choline as described in Materials and Methods. Results
are represented as the means 6 SD from three experiments performed in
duplicate. *p , 0.05 (t test) shows the statistically significant difference between
GTPγS independent and GTPγS dependent PLD activities.
dependent PLD activities. The GTPγS-dependent PLD activity indi-
cates involvement of GTP binding protein(s), usually the small molecu-
lar types (ARF and Rho family). When the control cells were incubated
with or without GTPγS for 60 min, PLD activities as determined by
released [3H]choline were 4.31 6 0.127 and 3.64 6 0.13 (% of total),
respectively. Thus there were statistically significant differences. By
contrast, the apoptotic cells treated with C2-ceramide (25 µM) for
12 h caused a reduction in both GTPγS-dependent and GTPγS-
independent PLD activity from 4.31 6 0.127 to 2.79 6 0.25 (% of
total) and from 3.64 6 0.13 to 2.56 6 0.32 (% of total), respectively,
suggesting no significant difference between these PLD activities in
the treated cells. Addition of phorbol myristate acetate (PMA) and
adenosine triphosphate did not affect the PLD activity in both types
of lysates (data not shown). Both GTPγS-dependent and GTPγS-
independent PLD activities in control cell lysates were inhibited by
addition of C2-ceramide to the assay system in a concentration
dependent manner (Fig 6). Fifty per cent of inhibition in the GTPγS-
dependent and GTPγS-independent PLD activities was observed at
µ60 µM of C2-ceramide.
To gain more information regarding the mechanism for decreased
PLD activity in the apoptotic cells induced by C2-ceramide, the effect
of C2-ceramide was examined in the membrane fraction prepared from
the control HaCaT cells. The membranes were incubated with GTPγS
(40 µM), rARF (5 µM), PMA (100 nM), adenosine triphosphate
(0.5 mM), or their combination in the presence of the cytosol fraction
(10 µg protein). As shown in Fig 7, rARF was the most potent
activator for the membrane associated PLD. In many other cell types,
PMA has been shown to exert a synergistic effect on ARF (Houle
et al, 1995; Singer et al, 1996). On the other hand, PMA had no
synergistic effect on ARF dependent PLD activity in HaCaT cells.
The ARF mediated enhancement of PLD activity in the membranes
was concentration and time dependent (data not shown). Addition of
C2-ceramide caused a concentration dependent inhibition of the ARF
dependent and independent PLD activities in the membranes (Fig 8).
ARF dependent and independent PLD activities of control were
6.81 6 0.16% (% of total) and 3.02 6 0.03% (% of total), respectively.
The ARF dependent and independent PLD activities were decreased
by 25 µM C2-ceramide to 64% and 45% of untreated cells, respectively.
It was of great interest to note that dihydroC2-ceramide being unable
to induce apoptosis did not affect both types of PLD activity. These
results suggest that the reduction of PLD activities in the apoptotic
Figure 6. Concentration dependence of C2-ceramide mediated
inhibition of PLD activities in cell lysates. The untreated control cells were
subjected to nitrogen cavitation for preparation of cell lysates. The PLD activities
were determined in the absence (s) or presence (d) of 40 µM GTPγS by
measuring released [3H]choline as described in Materials and Methods. Results
are represented as the means 6 SD from three experiments performed in
duplicate. *p , 0.05 (t test) shows the statistically significant difference between
GTPγS-independent and GTPγS-dependent PLD activities.
Figure 7. The effects of cytosolic activating factors on membrane
associated PLD activity. After nitrogen cavitation, the cell lysates were
centrifuged at 1500 3 g for 10 min, and the resultant supernatant was spun
down at 100,000 3 g for 60 min. The pelleted membranes were used for PLD
activity assay. The membrane fractions (5 µg protein) of HaCaT cells were
incubated for 60 min with GTPγS (40 µM), rARF (5 µM), PMA (100 nM),
and adenosine triphosphate (0.5 mM), or their combination in the presence of
cytosolic fractions (10 µg protein). Results are represented as the means 6 SD
from three experiments performed in duplicate.
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Figure 8. Effect of C2-ceramide on ARF independent (A) and ARF
dependent (B) membrane associated PLD activities. The membrane
fractions (1 µg protein) of HaCaT cells were incubated with various
concentrations of C2-ceramide (d) or dihydroC2-ceramide (s). The PLD
activities were determined in the absence (A) or presence (B) of rARF (5 µM)
as described in Materials and Methods. Data represent the means 6 SD of three
experiments performed in duplicate. PLD activities of control (without C2-
ceramide and dihydroC2-ceramide) were expressed as 100% [in the control cell
membranes, ARF independent PLD activity (A) is 3.02 6 0.03% (% of total)
and ARF dependent PLD activity (B) is 6.81 6 0.16% (% of total)].
HaCaT cell lysates may be due to inhibitory action of C2-ceramide
on membrane associated PLD activities.
DISCUSSION
In some cell types, apoptosis has been known to be induced by various
agents, e.g., dexamethasone, tumor necrosis factor-α (Larrick and
Wright, 1990), transforming growth factor-β, PMA (Kizaki et al, 1989),
retinoic acid, podophylling derivative etoposide, thromboxane A2
analog U46619, cycloheximide, and nitric oxide donors (Sarih et al,
1993); however, it has been reported that HaCaT keratinocyte is
resistant to these agents but apoptosis can be induced by UVB (Henseleit
et al, 1996), and only under the limited conditions. Reinartz et al
(1996) have demonstrated that in HaCaT cells tumor necrosis factor-
α induced apoptosis only in the presence of the cycloheximide, because
its apoptosis is counteracted by constitutively producing transforming
growth factor-α. In this study, we have demonstrated that a cell-
permeable C2-ceramide induced typical apoptosis in HaCaT cells. The
treatment of C2-ceramide resulted in several morphologic changes
characteristic of apoptosis, such as cell shrinkage, detachment from the
substratum, and blebbing of the plasma membrane. The Hoechst 33258
staining showed that apoptotic cells were markedly increased by
incubating with 25 and 50 µM C2-ceramide for 12 h, and that nearly
40% of the cells displayed apoptotic features. Ceramides have been
know to induce apoptosis in other cell types: HL-60 cells (Kim et al,
1991), U937 cells and fibroblasts (Obeid et al, 1993), mesencephalic
neurons (Brugg et al, 1996), PC12 cells (Hartfield et al, 1997), and C6
glial cells (Yoshimura et al, 1997). The concentration of C2-ceramide
to induce apoptosis in HaCaT cells was almost the same as that required
in C6 glial cells and the mesencephalic neurons, but was higher than
that required in human leukemic cell lines HL-60 and U937 cells (1–
5 µM). Substantial evidence has been presented that the generation of
endogenous ceramide is mediated by apoptosis inducing agonists such
as tumor necrosis factor-α, Fas ligand, and interleukin-1 (Hannun,
1996). A recent study has reported that 1α,25-dihydroxyvitamin D3
and its analog cause sphingomyelin hydrolysis to generate ceramide via
stimulating tumor necrosis factor-α mRNA expression in HaCaT cells
(Geilen et al, 1996, 1997); however, the exact mechanisms for the
ceramide induced apoptotic signaling involved in HaCaT cells remain
to be explored.
On the other hand, increasing evidence has accumulated that PLD
is implicated in cell proliferation and differentiation (Exton, 1994;
Liscovitch and Chalif, 1994). It was also shown that ceramides exert
inhibitory effects on PLD activation by agonists (Gomez-Mun˜oz et al,
1995; Nakamura et al, 1996; Abousalham et al, 1997). These observations
have prompted us to postulate that PLD could be somehow involved
in apoptosis. In fact, in this study it was shown that PLD activities
were suppressed in C2-ceramide induced apoptotic HaCaT cells. Our
recent studies have demonstrated that PLD activity was markedly
reduced in C2-ceramide induced apoptosis in rat C6 glial cells
(Yoshimura et al, 1997). We have further investigated the mechanism
underlying inhibition of PLD activity by ceramide in a cell-free system.
There are several stimulatory effectors for the regulation of PLD
activity, including PKC, low molecular weight GTP binding proteins
(ARF and Rho family proteins), and Ca21 and protein tyrosine
kinase(s) (Brown et al, 1993; Bowman et al, 1993; Cockcroft et al,
1994; Siddiqi et al, 1995; Ohguchi et al, 1996; Hammond et al, 1997;
Exton, 1997). It has recently been shown that C2-ceramide inhibits
PLD activity by preventing translocation of activators of GTPγS
stimulated PLD activity, such as PKC and ARF (Venable et al, 1996;
Abousalham et al, 1997). We have shown here that C2-ceramide
inhibited both GTPγS-dependent and GTPγS-independent PLD activ-
ities in the lysates of HaCaT cells, and also that both PLD activities
were decreased during apoptosis induced by C2-ceramide. Furthermore,
the results obtained in isolated membranes indicated that the membrane
associated PLD was extremely high in the basal activity independent
of cytosolic activating factors, such as ARF and PKC. This may suggest
the existence of a PLD2 type enzyme that is known to be absolutely
independent of these activating factors (Colley et al, 1997; Kodaki and
Yamashita, 1997). In fact, we have observed a high expression of PLD2
mRNA in HaCaT cells (unpublished observations). The membrane
associated ARF independent and ARF dependent PLD activities were
inhibited by C2-ceramide at a similar concentration (25 µM) to that
required for induction of apoptosis.
In conclusion, the results obtained here have indicated that C2-
ceramide induced apoptosis in HaCaT cells and inhibited both GTPγS-
dependent and GTPγS-independent PLD activities in a cell-free system.
Thus, it was suggested that C2-ceramides could be implicated in
apoptosis of keratinocyte HaCaT cells by suppressing PLD activity;
however, to prove this theory, further work, including the identification
of PLD isozymes involved in apoptosis, is required and is currently
under progress.
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